Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?-Reference-Cited by-同舟云学术

Genetic Testing for Cardiovascular Disease Susceptibility: A Useful Clinical Management Tool or Possible Misinformation?

Published:2004-04 Issue:4 Volume:24 Page:628-636
ISSN:1079-5642
Container-title:Arteriosclerosis, Thrombosis, and Vascular Biology
language:en
Short-container-title:ATVB

Author:

Humphries Steve E.¹,Ridker Paul M.¹,Talmud Philippa J.¹

Affiliation:

1. From Centre for Cardiovascular Genetics (S.E.H., P.J.T.), British Heart Foundation Laboratories, Rayne Building, Royal Free and University College London Medical School, London, UK; and The Centre for Cardiovascular Disease Prevention (P.M.R.), Divisions of Cardiovascular Diseases and Preventive Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference83 articles.

1. Goldstein JL Brown MS. Familial hypercholesterolemia. In: Scriver CH Beaudet AI Sly WS Valle D eds. The Metabolic Basis of Inherited Disease. New York: McGraw-Hill Book Co; 1989: 1215–1250.

2. A molecular genetic service for diagnosing individuals with familial hypercholesterolaemia (FH) in the United Kingdom

3. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands

4. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia

5. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study Commentary: Role of other genes and environment should not be overlooked in monogenic disease

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Decoding the Interplay of Genes and MicroRNAs in Cardiovascular Disease;Human Genetics and Genomics;2023-05-01

2. Apolipoprotein C-III and cardiovascular diseases: when genetics meet molecular pathologies;Molecular Biology Reports;2021-01

3. PHARMACOGENETIC CONSIDERATIONS OF ANTICOAGULANT MEDICATION;J PHYSIOL PHARMACOL;2018

4. Specific Issues in Clinical Genetics and Genetic Counselling Practices Related to Inherited Cardiovascular Conditions;Cardiovascular Genetics and Genomics;2018

5. Genetics of coronary artery disease and myocardial infarction;World Journal of Cardiology;2016